Medigene AG
Medigene AG MDG1.DE Peers
See (MDG1.DE) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| MDG1.DE | $0.13 | -27.64% | 1.97M | -0.11 | -$1.21 | N/A |
| NOV.DE | $60.60 | +1.69% | 257.35B | 20.00 | $3.03 | +1.01% |
| VX1.DE | $395.80 | +2.09% | 101.64B | -115.73 | -$3.42 | N/A |
| DUL.DE | $227.20 | N/A | 27.27B | -31.91 | -$7.12 | N/A |
| 22UA.F | $90.90 | +3.30% | 21.85B | -28.50 | -$3.19 | N/A |
| BM8.DE | $61.96 | -1.71% | 11.76B | 88.51 | $0.70 | N/A |
| 0QF.F | $25.04 | +8.19% | 9.68B | -3.21 | -$7.80 | N/A |
| EX9.DE | $32.28 | +1.22% | 9.21B | 35.47 | $0.91 | N/A |
| MOR.DE | $67.25 | -0.66% | 2.53B | -12.16 | -$5.53 | N/A |
| BBZA.DE | $31.40 | +0.80% | 1.72B | 12.82 | $2.45 | +6.40% |
Stock Comparison
MDG1.DE vs NOV.DE Comparison
MDG1.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDG1.DE stands at 1.97M. In comparison, NOV.DE has a market cap of 257.35B. Regarding current trading prices, MDG1.DE is priced at $0.13, while NOV.DE trades at $60.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDG1.DE currently has a P/E ratio of -0.11, whereas NOV.DE's P/E ratio is 20.00. In terms of profitability, MDG1.DE's ROE is -0.58%, compared to NOV.DE's ROE of +0.81%. Regarding short-term risk, MDG1.DE is more volatile compared to NOV.DE. This indicates potentially higher risk in terms of short-term price fluctuations for MDG1.DE.
MDG1.DE vs VX1.DE Comparison
MDG1.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDG1.DE stands at 1.97M. In comparison, VX1.DE has a market cap of 101.64B. Regarding current trading prices, MDG1.DE is priced at $0.13, while VX1.DE trades at $395.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDG1.DE currently has a P/E ratio of -0.11, whereas VX1.DE's P/E ratio is -115.73. In terms of profitability, MDG1.DE's ROE is -0.58%, compared to VX1.DE's ROE of -0.06%. Regarding short-term risk, MDG1.DE is more volatile compared to VX1.DE. This indicates potentially higher risk in terms of short-term price fluctuations for MDG1.DE.
MDG1.DE vs DUL.DE Comparison
MDG1.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDG1.DE stands at 1.97M. In comparison, DUL.DE has a market cap of 27.27B. Regarding current trading prices, MDG1.DE is priced at $0.13, while DUL.DE trades at $227.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDG1.DE currently has a P/E ratio of -0.11, whereas DUL.DE's P/E ratio is -31.91. In terms of profitability, MDG1.DE's ROE is -0.58%, compared to DUL.DE's ROE of +9.05%. Regarding short-term risk, MDG1.DE is more volatile compared to DUL.DE. This indicates potentially higher risk in terms of short-term price fluctuations for MDG1.DE.
MDG1.DE vs 22UA.F Comparison
MDG1.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDG1.DE stands at 1.97M. In comparison, 22UA.F has a market cap of 21.85B. Regarding current trading prices, MDG1.DE is priced at $0.13, while 22UA.F trades at $90.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDG1.DE currently has a P/E ratio of -0.11, whereas 22UA.F's P/E ratio is -28.50. In terms of profitability, MDG1.DE's ROE is -0.58%, compared to 22UA.F's ROE of -0.04%. Regarding short-term risk, MDG1.DE is more volatile compared to 22UA.F. This indicates potentially higher risk in terms of short-term price fluctuations for MDG1.DE.
MDG1.DE vs BM8.DE Comparison
MDG1.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDG1.DE stands at 1.97M. In comparison, BM8.DE has a market cap of 11.76B. Regarding current trading prices, MDG1.DE is priced at $0.13, while BM8.DE trades at $61.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDG1.DE currently has a P/E ratio of -0.11, whereas BM8.DE's P/E ratio is 88.51. In terms of profitability, MDG1.DE's ROE is -0.58%, compared to BM8.DE's ROE of +0.08%. Regarding short-term risk, MDG1.DE is more volatile compared to BM8.DE. This indicates potentially higher risk in terms of short-term price fluctuations for MDG1.DE.
MDG1.DE vs 0QF.F Comparison
MDG1.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDG1.DE stands at 1.97M. In comparison, 0QF.F has a market cap of 9.68B. Regarding current trading prices, MDG1.DE is priced at $0.13, while 0QF.F trades at $25.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDG1.DE currently has a P/E ratio of -0.11, whereas 0QF.F's P/E ratio is -3.21. In terms of profitability, MDG1.DE's ROE is -0.58%, compared to 0QF.F's ROE of -0.30%. Regarding short-term risk, MDG1.DE is more volatile compared to 0QF.F. This indicates potentially higher risk in terms of short-term price fluctuations for MDG1.DE.
MDG1.DE vs EX9.DE Comparison
MDG1.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDG1.DE stands at 1.97M. In comparison, EX9.DE has a market cap of 9.21B. Regarding current trading prices, MDG1.DE is priced at $0.13, while EX9.DE trades at $32.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDG1.DE currently has a P/E ratio of -0.11, whereas EX9.DE's P/E ratio is 35.47. In terms of profitability, MDG1.DE's ROE is -0.58%, compared to EX9.DE's ROE of +0.24%. Regarding short-term risk, MDG1.DE is more volatile compared to EX9.DE. This indicates potentially higher risk in terms of short-term price fluctuations for MDG1.DE.
MDG1.DE vs MOR.DE Comparison
MDG1.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDG1.DE stands at 1.97M. In comparison, MOR.DE has a market cap of 2.53B. Regarding current trading prices, MDG1.DE is priced at $0.13, while MOR.DE trades at $67.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDG1.DE currently has a P/E ratio of -0.11, whereas MOR.DE's P/E ratio is -12.16. In terms of profitability, MDG1.DE's ROE is -0.58%, compared to MOR.DE's ROE of +4.15%. Regarding short-term risk, MDG1.DE is more volatile compared to MOR.DE. This indicates potentially higher risk in terms of short-term price fluctuations for MDG1.DE.
MDG1.DE vs BBZA.DE Comparison
MDG1.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDG1.DE stands at 1.97M. In comparison, BBZA.DE has a market cap of 1.72B. Regarding current trading prices, MDG1.DE is priced at $0.13, while BBZA.DE trades at $31.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDG1.DE currently has a P/E ratio of -0.11, whereas BBZA.DE's P/E ratio is 12.82. In terms of profitability, MDG1.DE's ROE is -0.58%, compared to BBZA.DE's ROE of +0.05%. Regarding short-term risk, MDG1.DE is more volatile compared to BBZA.DE. This indicates potentially higher risk in terms of short-term price fluctuations for MDG1.DE.
MDG1.DE vs BIO3.DE Comparison
MDG1.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDG1.DE stands at 1.97M. In comparison, BIO3.DE has a market cap of 1.44B. Regarding current trading prices, MDG1.DE is priced at $0.13, while BIO3.DE trades at $29.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDG1.DE currently has a P/E ratio of -0.11, whereas BIO3.DE's P/E ratio is -47.30. In terms of profitability, MDG1.DE's ROE is -0.58%, compared to BIO3.DE's ROE of +0.05%. Regarding short-term risk, MDG1.DE is more volatile compared to BIO3.DE. This indicates potentially higher risk in terms of short-term price fluctuations for MDG1.DE.
MDG1.DE vs BIO.DE Comparison
MDG1.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDG1.DE stands at 1.97M. In comparison, BIO.DE has a market cap of 1.42B. Regarding current trading prices, MDG1.DE is priced at $0.13, while BIO.DE trades at $42.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDG1.DE currently has a P/E ratio of -0.11, whereas BIO.DE's P/E ratio is -67.62. In terms of profitability, MDG1.DE's ROE is -0.58%, compared to BIO.DE's ROE of +0.05%. Regarding short-term risk, MDG1.DE is more volatile compared to BIO.DE. This indicates potentially higher risk in terms of short-term price fluctuations for MDG1.DE.
MDG1.DE vs IMU.DE Comparison
MDG1.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDG1.DE stands at 1.97M. In comparison, IMU.DE has a market cap of 1.14B. Regarding current trading prices, MDG1.DE is priced at $0.13, while IMU.DE trades at $5.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDG1.DE currently has a P/E ratio of -0.11, whereas IMU.DE's P/E ratio is -9.22. In terms of profitability, MDG1.DE's ROE is -0.58%, compared to IMU.DE's ROE of -0.93%. Regarding short-term risk, MDG1.DE is more volatile compared to IMU.DE. This indicates potentially higher risk in terms of short-term price fluctuations for MDG1.DE.
MDG1.DE vs NVV1.F Comparison
MDG1.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDG1.DE stands at 1.97M. In comparison, NVV1.F has a market cap of 1.09B. Regarding current trading prices, MDG1.DE is priced at $0.13, while NVV1.F trades at $6.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDG1.DE currently has a P/E ratio of -0.11, whereas NVV1.F's P/E ratio is 2.74. In terms of profitability, MDG1.DE's ROE is -0.58%, compared to NVV1.F's ROE of -1.16%. Regarding short-term risk, MDG1.DE is more volatile compared to NVV1.F. This indicates potentially higher risk in terms of short-term price fluctuations for MDG1.DE.
MDG1.DE vs GBY.DE Comparison
MDG1.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDG1.DE stands at 1.97M. In comparison, GBY.DE has a market cap of 884.70M. Regarding current trading prices, MDG1.DE is priced at $0.13, while GBY.DE trades at $5.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDG1.DE currently has a P/E ratio of -0.11, whereas GBY.DE's P/E ratio is -4.38. In terms of profitability, MDG1.DE's ROE is -0.58%, compared to GBY.DE's ROE of -2.75%. Regarding short-term risk, MDG1.DE is more volatile compared to GBY.DE. This indicates potentially higher risk in terms of short-term price fluctuations for MDG1.DE.
MDG1.DE vs 5CV.F Comparison
MDG1.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDG1.DE stands at 1.97M. In comparison, 5CV.F has a market cap of 846.59M. Regarding current trading prices, MDG1.DE is priced at $0.13, while 5CV.F trades at $3.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDG1.DE currently has a P/E ratio of -0.11, whereas 5CV.F's P/E ratio is 5.22. In terms of profitability, MDG1.DE's ROE is -0.58%, compared to 5CV.F's ROE of +0.29%. Regarding short-term risk, MDG1.DE is more volatile compared to 5CV.F. This indicates potentially higher risk in terms of short-term price fluctuations for MDG1.DE.
MDG1.DE vs 5CV.DE Comparison
MDG1.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDG1.DE stands at 1.97M. In comparison, 5CV.DE has a market cap of 817.32M. Regarding current trading prices, MDG1.DE is priced at $0.13, while 5CV.DE trades at $3.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDG1.DE currently has a P/E ratio of -0.11, whereas 5CV.DE's P/E ratio is 5.04. In terms of profitability, MDG1.DE's ROE is -0.58%, compared to 5CV.DE's ROE of +0.29%. Regarding short-term risk, MDG1.DE is more volatile compared to 5CV.DE. This indicates potentially higher risk in terms of short-term price fluctuations for MDG1.DE.
MDG1.DE vs 2EM.DE Comparison
MDG1.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDG1.DE stands at 1.97M. In comparison, 2EM.DE has a market cap of 585.99M. Regarding current trading prices, MDG1.DE is priced at $0.13, while 2EM.DE trades at $11.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDG1.DE currently has a P/E ratio of -0.11, whereas 2EM.DE's P/E ratio is 34.38. In terms of profitability, MDG1.DE's ROE is -0.58%, compared to 2EM.DE's ROE of +0.20%. Regarding short-term risk, MDG1.DE is more volatile compared to 2EM.DE. This indicates potentially higher risk in terms of short-term price fluctuations for MDG1.DE.
MDG1.DE vs FYB.DE Comparison
MDG1.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDG1.DE stands at 1.97M. In comparison, FYB.DE has a market cap of 409.81M. Regarding current trading prices, MDG1.DE is priced at $0.13, while FYB.DE trades at $23.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDG1.DE currently has a P/E ratio of -0.11, whereas FYB.DE's P/E ratio is -3.23. In terms of profitability, MDG1.DE's ROE is -0.58%, compared to FYB.DE's ROE of -0.24%. Regarding short-term risk, MDG1.DE is more volatile compared to FYB.DE. This indicates potentially higher risk in terms of short-term price fluctuations for MDG1.DE.
MDG1.DE vs 2VSA.F Comparison
MDG1.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDG1.DE stands at 1.97M. In comparison, 2VSA.F has a market cap of 395.63M. Regarding current trading prices, MDG1.DE is priced at $0.13, while 2VSA.F trades at $7.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDG1.DE currently has a P/E ratio of -0.11, whereas 2VSA.F's P/E ratio is -2.20. In terms of profitability, MDG1.DE's ROE is -0.58%, compared to 2VSA.F's ROE of -5.83%. Regarding short-term risk, MDG1.DE is more volatile compared to 2VSA.F. This indicates potentially higher risk in terms of short-term price fluctuations for MDG1.DE.
MDG1.DE vs 88Q.DE Comparison
MDG1.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDG1.DE stands at 1.97M. In comparison, 88Q.DE has a market cap of 201.13M. Regarding current trading prices, MDG1.DE is priced at $0.13, while 88Q.DE trades at $13.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDG1.DE currently has a P/E ratio of -0.11, whereas 88Q.DE's P/E ratio is -13.98. In terms of profitability, MDG1.DE's ROE is -0.58%, compared to 88Q.DE's ROE of +3.45%. Regarding short-term risk, MDG1.DE is more volatile compared to 88Q.DE. This indicates potentially higher risk in terms of short-term price fluctuations for MDG1.DE.
MDG1.DE vs HPHA.DE Comparison
MDG1.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDG1.DE stands at 1.97M. In comparison, HPHA.DE has a market cap of 152.39M. Regarding current trading prices, MDG1.DE is priced at $0.13, while HPHA.DE trades at $3.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDG1.DE currently has a P/E ratio of -0.11, whereas HPHA.DE's P/E ratio is -7.27. In terms of profitability, MDG1.DE's ROE is -0.58%, compared to HPHA.DE's ROE of -0.63%. Regarding short-term risk, MDG1.DE is more volatile compared to HPHA.DE. This indicates potentially higher risk in terms of short-term price fluctuations for MDG1.DE.
MDG1.DE vs VSC.DE Comparison
MDG1.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDG1.DE stands at 1.97M. In comparison, VSC.DE has a market cap of 150.70M. Regarding current trading prices, MDG1.DE is priced at $0.13, while VSC.DE trades at $2.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDG1.DE currently has a P/E ratio of -0.11, whereas VSC.DE's P/E ratio is -7.27. In terms of profitability, MDG1.DE's ROE is -0.58%, compared to VSC.DE's ROE of -0.90%. Regarding short-term risk, MDG1.DE is more volatile compared to VSC.DE. This indicates potentially higher risk in terms of short-term price fluctuations for MDG1.DE.
MDG1.DE vs IF0.DE Comparison
MDG1.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDG1.DE stands at 1.97M. In comparison, IF0.DE has a market cap of 129.91M. Regarding current trading prices, MDG1.DE is priced at $0.13, while IF0.DE trades at $2.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDG1.DE currently has a P/E ratio of -0.11, whereas IF0.DE's P/E ratio is -2.43. In terms of profitability, MDG1.DE's ROE is -0.58%, compared to IF0.DE's ROE of -0.66%. Regarding short-term risk, MDG1.DE is more volatile compared to IF0.DE. This indicates potentially higher risk in terms of short-term price fluctuations for MDG1.DE.
MDG1.DE vs 94E.F Comparison
MDG1.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDG1.DE stands at 1.97M. In comparison, 94E.F has a market cap of 58.47M. Regarding current trading prices, MDG1.DE is priced at $0.13, while 94E.F trades at $0.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDG1.DE currently has a P/E ratio of -0.11, whereas 94E.F's P/E ratio is -1.37. In terms of profitability, MDG1.DE's ROE is -0.58%, compared to 94E.F's ROE of -0.43%. Regarding short-term risk, MDG1.DE is more volatile compared to 94E.F. This indicates potentially higher risk in terms of short-term price fluctuations for MDG1.DE.
MDG1.DE vs BNN.DE Comparison
MDG1.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDG1.DE stands at 1.97M. In comparison, BNN.DE has a market cap of 46.32M. Regarding current trading prices, MDG1.DE is priced at $0.13, while BNN.DE trades at $2.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDG1.DE currently has a P/E ratio of -0.11, whereas BNN.DE's P/E ratio is -3.72. In terms of profitability, MDG1.DE's ROE is -0.58%, compared to BNN.DE's ROE of -1.08%. Regarding short-term risk, MDG1.DE is more volatile compared to BNN.DE. This indicates potentially higher risk in terms of short-term price fluctuations for MDG1.DE.
MDG1.DE vs C6O.DE Comparison
MDG1.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDG1.DE stands at 1.97M. In comparison, C6O.DE has a market cap of 13.19M. Regarding current trading prices, MDG1.DE is priced at $0.13, while C6O.DE trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDG1.DE currently has a P/E ratio of -0.11, whereas C6O.DE's P/E ratio is -0.05. In terms of profitability, MDG1.DE's ROE is -0.58%, compared to C6O.DE's ROE of +1.21%. Regarding short-term risk, MDG1.DE is more volatile compared to C6O.DE. This indicates potentially higher risk in terms of short-term price fluctuations for MDG1.DE.
MDG1.DE vs GBMB.F Comparison
MDG1.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDG1.DE stands at 1.97M. In comparison, GBMB.F has a market cap of 12.56M. Regarding current trading prices, MDG1.DE is priced at $0.13, while GBMB.F trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDG1.DE currently has a P/E ratio of -0.11, whereas GBMB.F's P/E ratio is -0.08. In terms of profitability, MDG1.DE's ROE is -0.58%, compared to GBMB.F's ROE of -0.67%. Regarding short-term risk, MDG1.DE is more volatile compared to GBMB.F. This indicates potentially higher risk in terms of short-term price fluctuations for MDG1.DE.
MDG1.DE vs CNW.DE Comparison
MDG1.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDG1.DE stands at 1.97M. In comparison, CNW.DE has a market cap of 6.55M. Regarding current trading prices, MDG1.DE is priced at $0.13, while CNW.DE trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDG1.DE currently has a P/E ratio of -0.11, whereas CNW.DE's P/E ratio is -0.44. In terms of profitability, MDG1.DE's ROE is -0.58%, compared to CNW.DE's ROE of -0.49%. Regarding short-term risk, MDG1.DE is more volatile compared to CNW.DE. This indicates potentially higher risk in terms of short-term price fluctuations for MDG1.DE.
MDG1.DE vs LD6.F Comparison
MDG1.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDG1.DE stands at 1.97M. In comparison, LD6.F has a market cap of 4.37M. Regarding current trading prices, MDG1.DE is priced at $0.13, while LD6.F trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDG1.DE currently has a P/E ratio of -0.11, whereas LD6.F's P/E ratio is -1.01. In terms of profitability, MDG1.DE's ROE is -0.58%, compared to LD6.F's ROE of -3.29%. Regarding short-term risk, MDG1.DE is more volatile compared to LD6.F. This indicates potentially higher risk in terms of short-term price fluctuations for MDG1.DE.
MDG1.DE vs T5O.DE Comparison
MDG1.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDG1.DE stands at 1.97M. In comparison, T5O.DE has a market cap of 164400.00. Regarding current trading prices, MDG1.DE is priced at $0.13, while T5O.DE trades at $0.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDG1.DE currently has a P/E ratio of -0.11, whereas T5O.DE's P/E ratio is -0.25. In terms of profitability, MDG1.DE's ROE is -0.58%, compared to T5O.DE's ROE of -1.91%. Regarding short-term risk, MDG1.DE is less volatile compared to T5O.DE. This indicates potentially lower risk in terms of short-term price fluctuations for MDG1.DE.